Long-term post-LVAD surgery outcome in patients with and without pre-operative hemodynamic guided optimization

29 August 2020 (00:00 - 00:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Mr Jesse Feiko Veenis

Erasmus University Medical Center, Rotterdam (Netherlands (The))

6 More presentations in this session

Presentation thumbnail

Independent predictors of heart failure in patients with type 2 diabetes and chronic kidney disease: modeling from the CREDENCE trial

Doctor A. Sarraju (Stanford, US)

Abstract Slides Video

Presentation thumbnail

Serum uric acid, influence of sacubitril/valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON-HF

Doctor S. Selvaraj (Durham, US)

Abstract Slides Video

Presentation thumbnail

The renal and cardiovascular effects of SGLT2 inhibition in combination with loop diuretics in patients with type 2 diabetes and chronic heart failure (RECEDE-CHF) trial

Doctor N. Mordi (Dundee, GB)

Abstract Slides Video

Presentation thumbnail

Restricted mean survival time analysis in heart failure clinical trials

Doctor C. Perego (Cinisello Balsamo, IT)

Abstract Slides Video

Presentation thumbnail

Hybrid transcatheter and minimally invasive left ventricular reconstruction for the treatment of ischemic cardiomyopathy: mid-term results

Doctor P. Klein (Amsterdam, NL)

Abstract Slides Video

Access the full session

Session thumbnail

Novel Pharmacotherapies and Surgical Procedures for Heart Failure: How To Succeed?

The Event

ESC Congress 2020

29 August - 1 September 2020

You may be interested in

Congress Session

Navigating through heart failure device therapies

Congress Session

Which device might help your HFpEF patient?

Congress Session

Devices in acute heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources